Sarah Cannon Research Center

Nashville, Tennessee 37203

1 studies enrolling now · 5 studies all time

What they study most

Advanced Cancer, Advanced Solid Malignant Tumor, Angiosarcoma, Breast Cancer, Cancer, Colorectal Cancer, Liver Cancer, Locally Advanced Carcinoma, Metastatic Solid Tumor, Pancreatic Cancer, Prostate Cancer, Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma

Studies at this site

• A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors — Recruiting now
• Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. — Status unconfirmed
• Study to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma — Stopped early
• A Study of ARRY-334543 in Patients With Advanced Cancer — Completed
• A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer — Completed